All bones about it: a new treatment for GVHD - Surgery bone marrow transplantation is often regarded as one of the brightest lightsin the dark clouds of cancer treatment. The procedure has to be one of the consmeasures are most effective for the spread of cancer throughout the body, and has the distinction of being one of the less time consuming approach to cancer treatment.However, research and discoveries have shown that surgery bone marrow transplantation may not be as bright and shiny as once thought, with news about the side effects and complications that might arise from the wood. For one thing, the celltransplants can sometimes attack the new host body, which causes damage to the cellstructure, skin and internal organs.
The most known ways to help relieve the problems caused by this will use steroidsknown as prednison, usually lasts for a few weeks. A specially designed drugs to suppress immune cells and reduce inflammation and the damage they can cause,usually just long enough for the cells to fit into the host body. Steroids are known to be effective in reducing the problems caused by GVHD, but there are other factors to consider. Long-term use of the drug has a list of known psychoactive effects, such asviolent mood swings. There is a more severe side effects, such as muscle and bone maydamage, which can be fatal in certain situations. In such cases, doctors are often forced to prescribe a steroid to reduce the effects of other predsinone.
The food and Drug Administration (FDA) has just passed motion to prevent drug calledorBec from being released into the market. According to the manufacturer of the drug,it is designed as an alternative to predsinone, which can reduce the problems caused by GVHD but do not have the same level of toxicity. However, the FDA seems to find something distasteful about the drug and decided to keep it from entering the marketas a replacement for further testing. Redesigned from the steroid drugs often used byasthma patients, allowing for alleviation of symptoms without suppressing the immune system. However, the FDA has ruled that further testing needs to be done to determine whether or not there are any harmful side effects.
For the moment, there are some hospitals that have signed up to test the drug ontheir patients. Doctors also reported quite eager to get their hands on drugsexperiment, if only because it can reduce the burden of their patients. Constant recipessteroids due to GVHD can easily open a wide range of complications that may help avoid the use of orBec.
All bones about it: a new treatment for GVHD
This particular effect, known as Graft-Versus-Host Disease (GVHD), has been known to attack some patients transplant each year. The frequency and the severity of theproblem has been given the distinction of being the main problem faced by thoseundergoing bone marrow transplant operation. This occurs when bone marrowtransplants carry immune cells that are active with it. These cells Continue to attack thehost's body, believed to be a foreign entity. There are procedures in place to help prevent the problem, but as with all surgical procedures involving the transplantation,the possibility of contamination is always present and can only be minimized. |
| All bones about it: a new treatment for GVHD. pic:imagecache.artistrising.com |
The most known ways to help relieve the problems caused by this will use steroidsknown as prednison, usually lasts for a few weeks. A specially designed drugs to suppress immune cells and reduce inflammation and the damage they can cause,usually just long enough for the cells to fit into the host body. Steroids are known to be effective in reducing the problems caused by GVHD, but there are other factors to consider. Long-term use of the drug has a list of known psychoactive effects, such asviolent mood swings. There is a more severe side effects, such as muscle and bone maydamage, which can be fatal in certain situations. In such cases, doctors are often forced to prescribe a steroid to reduce the effects of other predsinone.
The food and Drug Administration (FDA) has just passed motion to prevent drug calledorBec from being released into the market. According to the manufacturer of the drug,it is designed as an alternative to predsinone, which can reduce the problems caused by GVHD but do not have the same level of toxicity. However, the FDA seems to find something distasteful about the drug and decided to keep it from entering the marketas a replacement for further testing. Redesigned from the steroid drugs often used byasthma patients, allowing for alleviation of symptoms without suppressing the immune system. However, the FDA has ruled that further testing needs to be done to determine whether or not there are any harmful side effects.
For the moment, there are some hospitals that have signed up to test the drug ontheir patients. Doctors also reported quite eager to get their hands on drugsexperiment, if only because it can reduce the burden of their patients. Constant recipessteroids due to GVHD can easily open a wide range of complications that may help avoid the use of orBec.
0 komentar
Post a Comment